Current Affairs - Technology - Discussion

ColoNoX is a nitric-oxide-releasing wound dressing introduced by the Department of Atomic Energy through BARC to address diabetic foot ulcers, a condition that often requires advanced therapeutic solutions due to slow healing and high infection risk. This innovation marks a major step in integrating nuclear research with biomedical applications, enabling controlled nitric oxide release that supports antimicrobial action, improved blood flow, and enhanced tissue repair. Its development strengthens India’s medical technology capabilities and demonstrates the potential of cross-disciplinary research in creating effective healthcare interventions for chronic and complex wounds.